Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lorrain

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Cardiovascular Pharmacology|April 1, 1988
Studies on the mechanisms of the development of tolerance to the hypotensive effects of fenoldopam in ratsF Lefèvre-Borg, J Lorrain, J Lechaire, et al.
The American Journal of Physiology|July 1, 1992
Adrenergic and nonadrenergic cotransmitters inhibit insulin secretion during sympathetic stimulation in dogsJ Lorrain, I Angel, N Duval, et al.
Obstetrics and Gynecology|November 1, 1993
Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histologyA H Ross, M E Boyd, T J Colgan, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1985
Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogsI Cavero, J Lorrain, E D Di Paola, et al.
Canadian Medical Association Journal|June 4, 1977
Glucagon secretion in pregnant women with suspected or mild diabetes mellitusJ Lorrain, R Robillard, A Cartier, et al.
Fundamental & Clinical Pharmacology|January 1, 1987
Cardiovascular characterization of the DA2 dopamine receptor agonist quinpirole in ratsF Lefevre-Borg, J Lorrain, J Lechaire, et al.
Journal of Thrombosis and Haemostasis : JTH|April 23, 2004
SSR182289A enhances thrombolysis induced by fibrinolytic agents in rabbit models of venous and arterial thrombosisC Visconte, M Sainte-Marie, J Lorrain, et al.
British Journal of Pharmacology|November 18, 2000
Pharmacological profile of SL 59.1227, a novel inhibitor of the sodium/hydrogen exchangerJ Lorrain, V Briand, E Favennec, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 23, 2003
Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitorJ Lorrain, L Millet, I Lechaire, et al.
Thrombosis and Haemostasis|April 20, 2001
Antiplatelet and antithrombotic activity of SL65.0472, a mixed 5-HT1B/5-HT2A receptor antagonistC N Berry, J Lorrain, S Lochot, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Cardiovascular Pharmacology|April 1, 1988
Studies on the mechanisms of the development of tolerance to the hypotensive effects of fenoldopam in ratsF Lefèvre-Borg, J Lorrain, J Lechaire, et al.
The American Journal of Physiology|July 1, 1992
Adrenergic and nonadrenergic cotransmitters inhibit insulin secretion during sympathetic stimulation in dogsJ Lorrain, I Angel, N Duval, et al.
Obstetrics and Gynecology|November 1, 1993
Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histologyA H Ross, M E Boyd, T J Colgan, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1985
Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogsI Cavero, J Lorrain, E D Di Paola, et al.
Canadian Medical Association Journal|June 4, 1977
Glucagon secretion in pregnant women with suspected or mild diabetes mellitusJ Lorrain, R Robillard, A Cartier, et al.
Fundamental & Clinical Pharmacology|January 1, 1987
Cardiovascular characterization of the DA2 dopamine receptor agonist quinpirole in ratsF Lefevre-Borg, J Lorrain, J Lechaire, et al.
Journal of Thrombosis and Haemostasis : JTH|April 23, 2004
SSR182289A enhances thrombolysis induced by fibrinolytic agents in rabbit models of venous and arterial thrombosisC Visconte, M Sainte-Marie, J Lorrain, et al.
British Journal of Pharmacology|November 18, 2000
Pharmacological profile of SL 59.1227, a novel inhibitor of the sodium/hydrogen exchangerJ Lorrain, V Briand, E Favennec, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 23, 2003
Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitorJ Lorrain, L Millet, I Lechaire, et al.
Thrombosis and Haemostasis|April 20, 2001
Antiplatelet and antithrombotic activity of SL65.0472, a mixed 5-HT1B/5-HT2A receptor antagonistC N Berry, J Lorrain, S Lochot, et al.
Pageof 3